Canadian-owned pharmaceutical company headquartered in St. Catharines (Ontario) since 1999, manufacturing sterile injectable oncology medicines such as paclitaxel derived from Canadian yew, supplying about 80% of Canada's paclitaxel market and international oncology centres.
Aucun commentaire disponible.
Laissez votre note & commentaire